StockVS

TSX · Drug Manufacturers - Specialty & Generic · CAD

Charlotte's Web Holdings, Inc. (CWEB.TO) Stock Analysis

Charlotte's Web Holdings, Inc. (CWEB.TO) is a Drug Manufacturers - Specialty & Generic stock listed on TSX and quoted in Canadian Dollar.

Last Updated: October 21, 2026

CWEB.TO

CA$0.35

+CA$0.01 (+2.94%)

Oct 21, 2026 · Market close

Compare

Price History

Hover for the daily close. The dotted line marks the period open.

Compare CWEB.TO with… →

CWEB.TO Key Statistics

As of Oct 21, 2026
Trading
Open
CA$0.36
Previous Close
CA$0.34
Day's Range
0.35–0.36
52-Week Range
0.11–1.33
Volume
3.50K
BetaHow much the share price moves relative to the wider market. 1.0 moves in line with it; above 1.0 swings more, below 1.0 less.
2.25
Valuation
Market Cap
CA$94.95M
P/E Ratio
unprofitable
Forward P/EShare price divided by forecast earnings for the year ahead, rather than the year just past.
25.59
P/S ratioMarket value divided by annual revenue. Useful for companies that are not yet profitable, where a P/E cannot be calculated.
2.03
EPS (ttm)Profit attributable to each share over the last twelve months.
−0.29
Financials (FY)
Revenue (FY)
CA$49.90M+0.46%
Net Income (FY)
−CA$29.74M
Profit marginThe share of revenue left as profit after all costs and taxes.
−73.61%
Shares OutstandingThe total number of shares held by all investors. Market value is this figure multiplied by the share price.
271.29M
1-Year Return
+40.00%
Dividend and dates
Earnings Date
November 11, 2026estimated
Avg Volume
62.41K

Only metrics the company reports are shown. Data provided by Yahoo Finance via yfinance. Updated daily.

Key facts

As of October 21, 2026, CWEB.TO closed at CA$0.35, +40.00% over 1 year.

Charlotte's Web Holdings, Inc. (CWEB.TO) has a market capitalization of CA$94.95M.

In fiscal 2025, CWEB.TO reported revenue of CA$49.90M.

CWEB.TO Stock Return by Calendar Year

Charlotte's Web Holdings, Inc. (CWEB.TO) return since Sep 2018: what CA$10,000 became

1 year
CA$10,000 CA$14,000
+40.00%
5 years
CA$10,000 CA$1,440
−85.60%
Since Sep 2018
CA$10,000 CA$242
−97.58%

If you had invested CA$10,000 in Charlotte's Web Holdings, Inc. (CWEB.TO) at the close on September 13, 2018, the earliest close on record here, it would have been worth CA$242 at the close on October 21, 2026: −97.58% in total, −36.81% a year, over a partial period shorter than 10 years. A historical calculation from closing prices adjusted for splits and dividends, before fees and taxes.

Calendar-year returns computed from daily closing prices. Partial years are shown muted and marked with an asterisk.

YearReturn
2026 (partial year)−30.00%
2025+284.62%
2024−51.85%
2023−63.01%
2022−42.97%
2021−69.45%
2020−57.85%
2019−34.48%
2018 (partial year)+4.98%

As of October 21, 2026.

CWEB.TO Revenue and Earnings by Fiscal Year

FY ends December
Fiscal yearRevenueNet incomeNet margin
2025CA$49.90M−CA$29.74M−59.6%
2024CA$49.67M−CA$29.85M−60.1%
2023CA$63.16M−CA$23.80M−37.7%
2022CA$74.14M−CA$59.31M−80.0%
Fiscal yearRevenueGross profitOperating incomeNet incomeNet margin
2025CA$49.90MCA$21.70M−CA$20.27M−CA$29.74M−59.6%
2024CA$49.67MCA$21.26M−CA$31.99M−CA$29.85M−60.1%
2023CA$63.16MCA$35.57M−CA$40.06M−CA$23.80M−37.7%
2022CA$74.14MCA$19.41M−CA$50.65M−CA$59.31M−80.0%

Annual figures as reported, in the company's reporting currency. As of December 31, 2025.

CWEB.TO Valuation vs Drug Manufacturers - Specialty & Generic Median

Median of 97 stocks
MetricCWEB.TODrug Manufacturers - Specialty & Generic medianvs median
P/S ratio2.032.103% below
Profit margin−73.61%−8.14%65.5 pts below

Medians across 97 Drug Manufacturers - Specialty & Generic stocks that report the metric. Medians, not averages, so one outlier cannot move them. As of October 21, 2026.

Analysis

Data-derived

Company Overview

Charlotte's Web Holdings, Inc. (CWEB.TO) is capitalised at CA$94.95M on the latest close. The company sits in the Healthcare sector, in the Drug Manufacturers - Specialty & Generic industry.

The 52-week range on file runs from CA$0.11 to CA$1.33. CWEB.TO last closed at CA$0.35 on October 21, 2026. That is +CA$0.01 (+2.94%) against the previous close. The latest close sits 218.18% above that 52-week low.

Financial Health

In fiscal 2025, Charlotte's Web Holdings, Inc. reported revenue of CA$49.90M. That is +0.46% against the prior fiscal year, when revenue was CA$49.67M. The same year closed with a net loss of CA$29.74M. The reported profit margin is −73.61%. That is 65.5 percentage points below the Drug Manufacturers - Specialty & Generic median of −8.14%. Trailing earnings per share are −0.29.

Across the 4 fiscal years on file, revenue moves from CA$74.14M in 2022 to CA$49.90M in 2025. Of those 4 years, 0 report positive net income.

Valuation Assessment

The record shows negative trailing earnings, so no price-to-earnings ratio is published. On forward earnings the ratio is 25.59. Measured against sales, the shares trade at 2.03 times revenue. On price-to-sales that is 3.47% below the Drug Manufacturers - Specialty & Generic median of 2.1. 97 Drug Manufacturers - Specialty & Generic companies report these metrics, and the medians quoted come from that group.

Over the trailing twelve months the total return is +40.00%. Measured over 5 years, that is −32.13% a year compounded. The reported beta is 2.25. Annualized volatility over the trailing 8 years is 103.15%.

Growth & Income

The record shows no dividend for CWEB.TO.

2026 is still running; the total return is −30.00% year to date. The strongest complete calendar year on file is 2025 at +284.62%; the weakest is 2021 at −69.45%. Of the 7 complete calendar years on file, 1 finished higher.

Peer Comparison

Charlotte's Web Holdings, Inc. (CWEB.TO) operates in the Drug Manufacturers - Specialty & Generic industry. Here is how it compares to its closest peers by market capitalization:

Company Ticker Market Cap P/E Ratio
Charlotte's Web Holdings, Inc. CWEB.TO CA$94.95M —
Takeda Pharmaceutical Company Limited TAK $63.67B —
Teva Pharmaceutical Industries Limited TEVA $47.37B 67.7
Haleon plc HLN $44.06B 20.5

Market caps are shown in each company's own trading currency, without conversion, and the peers are listed in order of these unconverted figures.

The Drug Manufacturers - Specialty & Generic industry average P/E ratio is 20.3x. Charlotte's Web Holdings, Inc. has no P/E ratio because it is not currently profitable.

Every figure above is read from this page's own data on each daily rebuild. Informational only, not financial advice. As of October 21, 2026.

Related Drug Manufacturers - Specialty & Generic Stocks

View all Drug Manufacturers - Specialty & Generic stocks →

Popular Healthcare Stocks

View all Healthcare stocks →

About Charlotte's Web Holdings, Inc.

Charlotte's Web Holdings, Inc. engages in the farming, manufacturing, marketing, and sale of hemp-derived cannabidiol (CBD) and botanical-based wellness products in the United States. The company offers full-spectrum hemp extract oil tinctures, such as liquid products; gummies; capsules; soft-gels; CBD topical creams and lotions; broad-spectrum botanical CBD; functional mushroom gummies; and pet products. Its products contain naturally occurring phytocannabinoids, including CBD, cannabichromene (CBC), cannabigerol (CBG), cannabinol (CBN), terpenes, flavonoids, and other beneficial hemp compounds. The company markets its products under the Charlotte's Web, Brightside, CBD Clinic, and CBD Medic brands. It distributes its products through its e-commerce website, third-party e-commerce websites, distributors, retailers, and healthcare practitioners. The company was formerly known as Stanley Brothers Holdings Inc. and changed its name to Charlotte's Web Holdings, Inc. in July 2018. Charlotte's Web Holdings, Inc. was founded in 2013 and is headquartered in Louisville, Colorado.

Visit website →